Transradial Access Devices Market Size By Product (Catheters, Guidewires, Sheath & Sheath Introducer, Accessories), By Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion, Diagnostic & Testing), By End-use (Hospitals & Cl

Transradial Access Devices Market Size By Product (Catheters, Guidewires, Sheath & Sheath Introducer, Accessories), By Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion, Diagnostic & Testing), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

Transradial Access Devices Market is anticipated to grow through 2032, owing to the rising inclination toward radial artery access for coronary intervention procedures. The product offers several benefits to patients, such as a reduced risk of bleeding, more comfort, a shorter recovery, and financial savings.

In addition, the growing geriatric population base will increase patient admissions for coronary diseases. According to the Journal of American Heart Association, between 55% to 98% of people above 60 years of age suffer from at least 2 chronic diseases. Furthermore, unhealthy habits such as smoking and alcohol consumption, along with a sedentary lifestyle, will stimulate the demand for advanced transradial access devices.

Overall, the transradial access devices market is segmented in terms of product, application, end-use, and region.

Considering the product, the guidewires segment will demonstrate sturdy growth through 2032. The smaller needle system in guidewires empower them to control better output and see blood flow immediately. Moreover, the product is used widely during radial artery catheterization as it reduces the difficulty in obtaining access. Besides, the rising demand for coronary catheterization is estimated to raise the adoption of guidewires.

Based on application, the drug administration segment is expected to depict over 6% CAGR during 2023-2032. The growth can be attributed to the rising burden of chronic diseases globally. In addition, the rising use of vascular access devices for drug administration, especially for treating cancer and other infectious diseases, will assist the market growth in the near future.

Based on end-use, the ambulatory surgical centers segment will grow considerably through 2032. According to recent studies, some selected morbidly obese patients can safely undergo surgery on an ambulatory basis which is anticipated to positively enhance the demand for transradial access devices. Some pivotal ASC benefits including lower cost of care, reduced stress, convenience, and accessibility, would further stimulate the market growth prospects.

Regionally, the North America transradial access devices market accounted for over 31% market share in 2022. The increasing prevalence of cardiac diseases in American economies will be a key element in fostering the regional expansion by 2032 end. According to credible reports, the CVD cases are constantly rising across the continent. Besides, increasing obese patients susceptible to cardiac disease will boost regional growth. In addition, the presence of some of the leading key players who are constantly investing in R&D activities of vascular access devices will prompt the demand for transradial access devices during the estimated timeframe.